{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:04:27Z","timestamp":1792440267682,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Liver cancer remains a significant global health concern, with hepatitis B virus (HBV) as the leading cause. This study aims to systematically evaluate the global epidemiological burden, risk factors, and long-term trends of HBV-related liver cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data from the Global Burden of Disease (GBD) study 2021 were used to analyze incidence, deaths, and prevalence rates of HBV-related liver cancer across 204 countries and territories. Age-period-cohort (APC) models were applied to assess age-specific trends, period effects, and cohort impacts on age-standardized disease burden. Pearson correlation analyses examined the relationship between liver cancer burden, the socio-demographic index (SDI), and the universal health coverage (UHC) index. We also evaluated the influence of other concomitant risk factors on HBV-related liver cancer deaths. Projections for future death trends were generated using Bayesian APC models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In 2021, there were 206,365.7 new cases of HBV-related liver cancer and 181,194.3 deaths worldwide. Between 1990 and 2021, both the global age-standardized incidence rate (ASIR) and age-standardized prevalence rate (ASPR) showed an upward trend. The age-standardized death rate (ASDR) declined, particularly in middle SDI countries, where the ASDR dropped by 21.7%. Incidence rates decreased among individuals under 70 years old, while death rates dropped for those under 75 years. Period trends revealed an increase in incidence and deaths from 1995 to 2000, followed by a sharp decline from 2000 to 2010, with death reductions being more pronounced. The downward trend was most notable among birth cohorts from the 1970s onward. A negative correlation was found between the SDI, the UHC, and liver cancer burden. The number of deaths attributable to risk factors increased by 97.8% from 1990 to 2021. Projections indicate a 30.2% reduction in HBV-related liver cancer deaths globally by 2040.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The global burden of HBV-related liver cancer showed significant regional disparities and presented ongoing global health challenges. Socioeconomic factors and healthcare access are closely associated with disease burden. Effective, region-specific interventions are essential to mitigate future HBV-related liver cancer burdens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003787","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:00:09Z","timestamp":1761966009000},"page":"3457-3466","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Global epidemiology of liver cancer burden due to hepatitis B virus: A comprehensive estimate based on Global Burden of Disease Study 2021"],"prefix":"10.1097","volume":"138","author":[{"given":"Mengdi","family":"Cao","sequence":"first","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfa","family":"Xia","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Teng","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianru","family":"Li","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuopei","family":"Tan","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Wang","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zuo","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Li","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Zheng","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Chen","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"R1-20260407","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260407","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.livres.2024.05.004","article-title":"Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do","volume":"8","author":"Abdelhamed","year":"2024","journal-title":"Liver Res"},{"key":"R4-20260407","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.3748\/wjg.v28.i29.3793","article-title":"Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma","volume":"28","author":"Gnyawali","year":"2022","journal-title":"World J Gastroenterol"},{"key":"R5-20260407","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1158\/1055-9965.EPI-20-1088","article-title":"Disparities in hepatocellular carcinoma incidence, stage, and survival: A large population-based study","volume":"30","author":"Flores","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R6-20260407","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jhep.2023.12.031","article-title":"Inequities in primary liver cancer in Europe: The state of play","volume":"80","author":"Kondili","year":"2024","journal-title":"J Hepatol"},{"key":"R7-20260407","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: Current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R8-20260407","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R9-20260407","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R10-20260407","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/1055-9965.EPI-11-0421","article-title":"Age-period-cohort models in cancer surveillance research: Ready for prime time?","volume":"20","author":"Rosenberg","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R11-20260407","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/03014460.2019.1707872","article-title":"Age period cohort analysis: A review of what we should and shouldn\u2019t do","volume":"47","author":"Bell","year":"2020","journal-title":"Ann Hum Biol"},{"key":"R12-20260407","doi-asserted-by":"crossref","first-page":"101249","DOI":"10.1016\/j.eclinm.2021.101249","article-title":"Global, regional, and national time trends in mortality for congenital heart disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study","volume":"43","author":"Su","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R13-20260407","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: A register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"R14-20260407","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jiph.2019.08.004","article-title":"Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action","volume":"13","author":"Al Awaidy","year":"2020","journal-title":"J Infect Public Health"},{"key":"R15-20260407","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","article-title":"Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: Burden, trends, challenges and future directions","volume":"21","author":"Mak","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R16-20260407","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2893.2009.01117.x","article-title":"Hepatitis B-related hepatocellular carcinoma: Epidemiological characteristics and disease burden","volume":"16","author":"Nguyen","year":"2009","journal-title":"J Viral Hepat"},{"key":"R17-20260407","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/1753-6405.12889","article-title":"Increasing incidence and mortality related to liver cancer in Australia: Time to turn the tide","volume":"43","author":"Cocker","year":"2019","journal-title":"Aust N Z J Public Health"},{"key":"R18-20260407","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/cam4.4530","article-title":"The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels","volume":"11","author":"Yang","year":"2022","journal-title":"Cancer Med"},{"key":"R19-20260407","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1038\/s41467-021-26475-6","article-title":"The impact of the timely birth dose vaccine on the global elimination of hepatitis B","volume":"12","author":"de Villiers","year":"2021","journal-title":"Nat Commun"},{"key":"R20-20260407","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0928-4346(96)82012-3","article-title":"Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992","volume":"5","author":"Xia","year":"1996","journal-title":"Int Hepatol Commun"},{"key":"R21-20260407","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3201\/eid2305.161477","article-title":"Prevention of chronic hepatitis b after 3 decades of escalating vaccination policy, China","volume":"23","author":"Cui","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"R22-20260407","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R23-20260407","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S1473-3099(24)00308-6","article-title":"WHO\u2019s 2024 guidelines to combat hepatitis B","volume":"24","author":"Bagcchi","year":"2024","journal-title":"The Lancet Infectious Diseases"},{"key":"R24-20260407","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2468-1253(24)00089-X","article-title":"WHO 2024 hepatitis B guidelines: An opportunity to transform care","volume":"9","author":"Easterbrook","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R25-20260407","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2468-1253(23)00455-7","article-title":"Urgent need for lived experience in hepatitis B guideline development","volume":"9","author":"Freeland","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R26-20260407","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for hepatitis B virus infection: CDC recommendations - United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"R27-20260407","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/cid\/ciab405","article-title":"Cost-effectiveness of 1-time universal screening for chronic hepatitis b infection in adults in the United States","volume":"74","author":"Toy","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R28-20260407","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jhep.2023.02.022","article-title":"International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance","volume":"79","author":"Singal","year":"2023","journal-title":"J Hepatol"},{"key":"R29-20260407","doi-asserted-by":"crossref","first-page":"100963","DOI":"10.1016\/j.lanepe.2024.100963","article-title":"Improving hepatocellular carcinoma surveillance in the United\u00a0Kingdom: Challenges and solutions","volume":"43","author":"Qurashi","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"R30-20260407","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/1940-6207.CAPR-12-0046","article-title":"Failure rates in the hepatocellular carcinoma surveillance process","volume":"5","author":"Singal","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"R31-20260407","first-page":"101129","article-title":"A new hepatitis B elimination strategy for remote populations is needed","volume":"48","author":"Lee","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"R32-20260407","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/dar.13286","article-title":"The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification","volume":"40","author":"Rehm","year":"2021","journal-title":"Drug Alcohol Rev"},{"key":"R33-20260407","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jgh.12700","article-title":"Hepatitis B virus infection and metabolic syndrome: Fact or fiction?","volume":"30","author":"Wang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-20260407","first-page":"679","article-title":"Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: Profiles and changing trends","volume":"21","author":"Cao","year":"2024","journal-title":"Cancer Biol Med"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:02:57Z","timestamp":1775592177000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":33,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003787","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-04-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}